Medical devices, healthcare technology and the business of care
510(k) clearance · K262781

LED Light Therapy Mask (4D Glow Mask FM19-0K, 4D Glow Mask FM19-1K, 4D Glow Mask FM19-2K, 4D Glow Mask FM19-VK, 4D Glow Mask FM35-0K, 4D Glow Mask FM35-1K, 4D Glow Mask FM35-2K, 4D Glow Mask FM35-VK)

Guangdong Newdermo Biotech Co., Ltd. · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONK262781

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-11-04 for K262781, a traditional 510(k) submitted by Guangdong Newdermo Biotech Co., Ltd. The device is listed as an LED Light Therapy Mask under the 4D Glow Mask name, with model designators FM19-0K, FM19-1K, FM19-2K, FM19-VK, FM35-0K, FM35-1K, FM35-2K and FM35-VK. The application was received on 08/06/2026 and falls under regulation 878.4810, product code OHS, in the General & Plastic Surgery specialty.

SESE means the submission was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record shows no third-party review, no combination product status and no authorized predetermined change control plan. The public page does not state the predicate device, the specific model differences, or any clinical or performance data supporting equivalence, so those points remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Nov 4, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262781
Regulatory pathway
510(k) premarket notification
Product code
OHS
Decision code
SESE
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light Based Over The Counter Wrinkle Reduction.

Product code
OHS
FDA device class
2

FDA decision timeline

  1. K262781 received

    Application receipt date recorded by FDA.

  2. K262781 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OHS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Guangdong Newdermo Biotech Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Guangdong

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records